Insider Trades of ORBIMED ADVISORS LLC Information

Click on the column header to resort ascending (▲) or descending (▼).

Individual Insider Trades

Company Relation Last Date Type Tran ▼ OwnerType Shares Traded Last Price Shares Held
SUPERNUS PHARMACEUTICALS INC Beneficial Owner (10%) 12/17/2012 Form 4 Sell indirect 197,815 6.8479 100,000
SUPERNUS PHARMACEUTICALS INC Beneficial Owner (10%) 12/18/2012 Form 4 Sell indirect 100,000 7.0767
SUPERNUS PHARMACEUTICALS INC Beneficial Owner (10%) 02/12/2013 Form 4 Sell indirect 152,183 7.5218 858,100
SUPERNUS PHARMACEUTICALS INC Beneficial Owner (10%) 02/13/2013 Form 4 Sell indirect 150,000 7.5757 817,000
INTERCEPT PHARMACEUTICALS INC Director 10/15/2013 Form 4 Sell indirect 376,585 62.5 1,775,347
INTERCEPT PHARMACEUTICALS INC Director 10/21/2013 Form 4 Sell indirect 40,088 62.5 1,735,259
INTERCEPT PHARMACEUTICALS INC Director 04/09/2014 Form 4 Sell indirect 81,305 320 1,654,603
MIRATI THERAPEUTICS, INC. Beneficial Owner (10%) 06/27/2014 Form 4 Sell indirect 88,332 21.79 1,186,000
MIRATI THERAPEUTICS, INC. Beneficial Owner (10%) 06/30/2014 Form 4 Sell indirect 14,000 20.33 1,172,000
MIRATI THERAPEUTICS, INC. Beneficial Owner (10%) 07/01/2014 Form 4 Sell indirect 5,000 20.04 1,167,000
INTERCEPT PHARMACEUTICALS INC Director 08/14/2014 Form 4 Sell indirect 60,000 292.701 1,596,582
RELYPSA INC Beneficial Owner (10%) 08/15/2014 Form 4 Sell indirect 990,000 26.35 8,951,551
INTERCEPT PHARMACEUTICALS INC Director 08/25/2014 Form 4 Sell indirect 50,000 294.67 1,546,582
INTERCEPT PHARMACEUTICALS INC Director 08/26/2014 Form 4 Sell indirect 61,258 299.13 1,485,324
RELYPSA INC Beneficial Owner (10%) 11/20/2013 Form 4 Disposition (Non Open Market) indirect 27,282 11 8,907,342
INTERCEPT PHARMACEUTICALS INC Beneficial Owner (10%) 10/16/2012 Form 4 Buy indirect 333,334 15 2,150,634
AMBIT BIOSCIENCES CORP Beneficial Owner (10%) 05/20/2013 Form 4 Buy indirect 10,600 6.7773 10,807
AMBIT BIOSCIENCES CORP Beneficial Owner (10%) 05/21/2013 Form 4 Buy indirect 669,871 6.897 1,443,222
AMBIT BIOSCIENCES CORP Beneficial Owner (10%) 05/22/2013 Form 4 Buy indirect 21,300 6.861 1,464,322
AMBIT BIOSCIENCES CORP Beneficial Owner (10%) 05/23/2013 Form 4 Buy indirect 12,500 6.9893 1,476,702